Verapamil is a calcium channel blocker that modulates neuronal excitability by inhibiting voltage-dependent calcium influx, potentially reducing aberrant cortical hyperactivity associated with Visual Snow Syndrome. By decreasing neuronal excitation and stabilizing neuronal membranes, it may help mitigate the persistent visual disturbances and neurological symptoms characteristic of the syndrome.